The 20 Best Long Haul COVID Doctors in Maryland, US

Dr. Annie Antar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and infectious diseases. Her areas of research expertise include long COVID, long COVID in people living with HIV, HIV cure, and suboptimal CD4 response after antiretroviral therapy. Dr. Antar earned her undergraduate degree from Harvard University and her M.D. and Ph.D. degrees from Vanderbilt University School of Medicine. She completed both her residency in internal medicine and fellowship in infectious diseases at the Johns Hopkins Hospital. Dr. Antar is rated as a Distinguished provider by MediFind in the treatment of Long Haul COVID. Her top areas of expertise are Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), COVID-19, and HIV/AIDS.

Theodore Iwashyna is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Iwashyna is rated as an Advanced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS), Cerebral Hypoxia, and COVID-19.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Advanced provider by MediFind in the treatment of Long Haul COVID. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

Dr. Ann Marie Parker is an instructor of medicine at the Johns Hopkins University School of Medicine. Her clinical focus is in pulmonary and critical care medicine, with a special interest in critically ill oncology patients as well as delirium and rehabilitation in the ICU. She earned her M.D. at the University of Maryland School of Medicine. She completed her residency at the University of Maryland Medical Center and a fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Parker joined the Johns Hopkins faculty in 2016. Dr. Parker is rated as an Advanced provider by MediFind in the treatment of Long Haul COVID. Her top areas of expertise are Long Haul COVID, Acute Respiratory Distress Syndrome (ARDS), Severe Acute Respiratory Syndrome (SARS), COVID-19, and Pancreaticoduodenectomy.

Brian Agan is an Infectious Disease provider in Bethesda, Maryland. Dr. Agan is rated as a Distinguished provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are HIV/AIDS, Syphilis, Long Haul COVID, and COVID-19.

Jacques Conaway is an Intensive Care Medicine provider in Berlin, Maryland. Dr. Conaway is rated as an Advanced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Drowsiness, and Excessive Daytime Sleepiness.

Nikhil Huprikar is an Intensive Care Medicine provider in Columbia, Maryland. Dr. Huprikar is rated as an Advanced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are COVID-19, Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), and Eosinophilic Pneumonia.

Surjit Julka is an Intensive Care Medicine provider in Owings Mills, Maryland. Dr. Julka is rated as an Advanced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Asthma in Children, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Lung Metastases.

Daniel Shinners is a Pulmonary Medicine provider in Bel Air, Maryland. Dr. Shinners is rated as an Advanced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Lung Nodules, and Pulmonary Fibrosis.

Vinay Sharma, MD, specializes in pulmonary critical care and is board-certified in critical care medicine and pulmonary disease by the American Board of Internal Medicine. He practices at UPMC Western MD Specialty Services - Pulmonary Diseases/CCM. Dr. Sharma completed his medical degree at Maulana Azad Medical College, residency at Department of Veterans Affairs Medical Center, and fellowship at MCP Hahnemann University/Drexel and the University of Medicine and Dentistry of New Jersey. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pneumonia, Liver Embolization, and Gastrostomy.

Dr. Galiatsatos is a pulmonary and critical care medicine physician. He is an expert in the diagnosis and treatment of obstructive lung disease, tobacco cessation, and in the care of critically ill patients in the Medical ICU. He is a member of the Obstructive Lung Disease Group at Johns Hopkins, oversees the Tobacco Treatment Clinic and provides teaching to medical students and residents at Johns Hopkins. Dr. Galiatsatos is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), COVID-19, Severe Acute Respiratory Syndrome (SARS), and Pneumonia.

Dr. Bailey received his M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine through the Medical Scientist Training Program and completed medical residency at the Massachusetts General Hospital. He subsequently completed fellowship training in Infectious Diseases at the Johns Hopkins University School of Medicine before transitioning to a faculty position. His primary clinical interests are management and treatment of HIV and viral hepatitis, including hepatitis c virus. His research interests include the study of human B cells and neutralizing antibody responses against hepatitis C virus (HCV), hepatitis B virus (HBV), SARS-CoV-2, and respiratory syncytial virus (RSV), with the goal of developing improved vaccines against these viruses. Dr. Bailey is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Hepatitis C, Hepatitis, COVID-19, and HIV/AIDS.

Dr. Andrea L. Cox is a professor of Internal Medicine at the Johns Hopkins University School of Medicine in the Division of Infectious Diseases and is a member of the Johns Hopkins Kimmel Cancer Center. She holds joint appointments in Oncology and at the Johns Hopkins Bloomberg School of Public Health, in Molecular Microbiology and Immunology. She is an internationally recognized leader in studies of immune responses in immunocompetent and immunocompromised patient populations to viral infections and vaccines against them, including SARS-Co-V-2 (the virus that causes COVID-19), HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Dr. Cox earned her Ph.D. in chemistry from the University of Virginia, where she characterized peptides that drive T cell responses. She then earned her M.D. and completed internal medicine residency and infectious disease fellowship training at Johns Hopkins. She leads the largest prospective cohort study of acute HCV infection, designed to enable detailed molecular analysis of HCV transmission, host immune responses, and virus sequence evolution. She co-led the first prophylactic HCV vaccine trial in individuals at risk of HCV infection. She leads a multidisciplinary international team investigating HCV-specific immune responses to improve vaccine development against HCV, is the lead immunologist on a clinical trial of HBV vaccines in people living with HIV, and co-leads a large team investigating immune responses to COVID-19 infection and vaccines. In addition to her research on viral infections and vaccines, Dr. Cox is actively involved in clinical care of patients with HCV, HIV, and HBV infections. Dr. Cox serves as the director of the Medical Scientist Training Program. A teacher, advisor, and mentor of physician-scientists and scientists, Dr. Cox mentors Ph.D. students in the Johns Hopkins Cellular and Molecular Medicine, Molecular Microbiology and Immunology, and the Immunology graduate training programs. Dr. Cox is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. Her top areas of expertise are Hepatitis C, Hepatitis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Ike Ekekwe, M.D., is a pulmonologist with Johns Hopkins Community Physicians. Dr. Ekekwe started his professional career with the Pulmonary Critical Care and Sleep Division at Saint Peters University Hospital in New Brunswick, New Jersey. Following that, he worked on the Pulmonary, Critical Care, and Sleep Medicine team at Piedmont Health Care Systems in Fayetteville, Georgia, for many years. He is excited to continue his professional career with Johns Hopkins Community Physicians. Dr. Ekekwe enjoys caring for patients with pulmonary and sleep disorders, both in the clinic and at the hospital. Outside of work, he spends time with his family and enjoys watching soccer. Dr. Ekekwe is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Obstructive Sleep Apnea, Pneumonia, Lung Metastases, Pneumocystis Jiroveci Pneumonia, and Gastrostomy.

Jeff Tornheim, M.D., MPH, is a member of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network, and is a term member of the Council on Foreign Relations. Dr. Tornheim graduated with a B.A. in International Development and Economics from Brandeis University, received his medical and public health degree from the Mount Sinai School of Medicine, completed a combined residency in Internal Medicine and Pediatrics at Yale University School of Medicine and a clinical fellowship in Infectious Diseases at Johns Hopkins University School of Medicine. Prior to completing his medical education, he worked on strengthening health systems for returning refugees to South Sudan, studied the epidemiology of pneumonia and diarrhea in Kenya with the Centers for Disease Control and Prevention (CDC) International Emerging Infections Program, studied adherence to latent tuberculosis treatment at the New York City Department of Health and Mental Hygiene in the Bureau of TB Control, and volunteered in an East Harlem free clinic. During his public health degree, he evaluated the impact of water policy on rates of pediatric diarrhea as well as Chagas Disease epidemiology and treatment in Bolivia through the Fogarty International Clinical Scholars Program. His interest in clinical outcomes for underserved populations has led to research, teaching, and clinical practice in Bolivia, India, Kenya, Peru, Rwanda, South Africa, South Sudan, Uganda, and the United States. His current NIH-supported research explores the application of whole genome sequencing, drug level testing, transcriptional and metabolomic profiling, and biomarker assessments to improved health outcomes in the treatment of adults and children with drug resistant tuberculosis in India. Dr. Tornheim is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Long Haul COVID, Malnutrition, Bacterial Meningitis, and HIV/AIDS.

Dr. John Aucott is an associate professor of medicine at the Johns Hopkins University School of Medicine. An internist and Lyme disease expert in the Division of Rheumatology, he is the director of the Johns Hopkins Lyme Disease Clinical Research Center. With more than 15 years of research experience on the crippling effects of Lyme disease, he has published studies focusing on characteristics of early Lyme disease differences in males and females with an emphasis on prospects for prevention, diagnosis and treatment. Dr. Aucott received his medical degree from the Johns Hopkins University School of Medicine. He completed his residency in internal medicine at the University Hospitals of Cleveland. He is fellowship-trained in infectious disease and geographic medicine. Dr. Aucott and his colleagues were recognized by Johns Hopkins with a Discovery Fund Synergy Award in 2014. Dr. Aucott is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Lyme Disease, Synovitis, Reactive Arthritis, and Long Haul COVID.

Janice Lee, MD, specializes in pulmonology and is board-certified in critical care medicine, internal medicine, and pulmonary disease by the American Board of Internal Medicine. She practices at UPMC Western Maryland Pulmonary Physicians. Dr. Lee completed her fellowship at SUNY Stony Brook School of Medicine, residency at Pennsylvania Hospital, and medical education at the University of Queensland. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. Her top areas of expertise are Asthma in Children, Asthma, Lung Metastases, and Chronic Obstructive Pulmonary Disease (COPD).

1988-1992, Assistant Professor, Department of Pharmacology, Semmelweis Medical University, Budapest, Hungary. 1992-1996, Instructor, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 2001-2014, Assistant Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2012-2014, Assistant Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Associate Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. Dr. Yasar is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. Her top areas of expertise are Normal Pressure Hydrocephalus, Congenital Cardiovascular Shunt, Dementia, and Alzheimer's Disease.

Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin. Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. He earned his M.D. from the Columbia University College of Physicians and Surgeons. His research interests include tick-borne diseases and point of care information technology. Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America. Dr. Auwaerter is rated as an Experienced provider by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Lyme Disease, Infectious Myocarditis, Babesiosis, and Osteomyelitis.